Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, staphylococcal enterotoxin A, and purified protein derivative

Immunopharmacology

Volumn 31, Issue 1, 1995, Pages 109-116

  Shannon, E J ^a   Sandoval, Felipe ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Interleukin 2; Thalidomide

Indexed keywords

ANTIGEN; CONCANAVALIN A; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MITOGENIC AGENT; RADIOISOTOPE; STAPHYLOCOCCUS ENTEROTOXIN A; THALIDOMIDE; THYMIDINE; TUBERCULIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; PRIORITY JOURNAL;

CELLS, CULTURED; CONCANAVALIN A; ENTEROTOXINS; FEMALE; HUMAN; INTERLEUKIN-2; KINETICS; MALE; MONOCYTES; THALIDOMIDE; TUBERCULIN;

EID: 0028807544     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(95)00039-7     Document Type: Article

References (25)

1. Studies on T-cell subsets and functions in leprosy
2. Kinetics of IL-2 and interferon-y production, expression on IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A
3. The metabolic fate of thalidomide
4. T lymphocyte activation by Staphylococcal Enterotoxins Role of Class II molecules and T cell surface structures
5. Thalidomide: Treatment of choice for aphthous ulcers in patients seropositive for human immunodeficiency virus
6. The spectrophotometric determination of thalidomide in body fluids
7. Thalidomide in human immunodeficiency virus (HIV) patients
8. Immunological effects of thalidomide
9. Studies on the mechanism of action of thalidomide in leprosy
10. Immunosuppresive properties of thalidomide Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK 506
11. Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum
12. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Thl cytokine production in mitogen-and antigen-stimulated human peripheral blood mononuclear cell cultures
13. Reply to the Editor
14. In situ characterization of T lymphocyte subsets in the reactional states of leprosy
15. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum
16. Hypothesis: Erythema nodosum leprosum is precipitated by an imbalance of T lymphocytes
17. (S) form of α-methyl-n(a)-phthalimidoglutarimide, but not its (R) -form, enhanced phorsol ester-induced tumor necrosis factor-a production by human leukemia cell IL-60: Implication of optical resolution of thalidomidal effects
18. Enhancement of phorbol ester-induced production of tumor necrosis factor a by thalidomide
19. Letter
20. Epidermal keratinocyte la expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy
21. Thalidomide selectively inhibits tumor necrosis factor a production by stimulated human monocytes
22. Thalidomide does not affect selected immunomodulating cell surface receptor molecules on cells with immune potential nor does it affect synthesis of selected cytokines from these cells
23. Thalidomide does not perturb CD2 CD4 CD5 CD8 HLA-DR or HLA-ABC molecules on the membranes of cells with immune potential
24. An improved colorimetric assay for interleukin-2
25. Letter